Cormorant Private Healthcare Fund III LP Net Worth - Insider Trades and Bio as of May 7, 2026

Cormorant Private Healthcare Fund III LP's Net Worth

Estimate Recalculated May 7, 2026 10:29AM EST

Who is Cormorant Private Healthcare Fund III LP

Cormorant Private Healthcare Fund III LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Ambrx Biopharma, Inc., Design Therapeutics, Inc., Icosavax, Inc., Ventyx Biosciences, Inc., Tyra Biosciences, Inc., Monte Rosa Therapeutics, Inc., Verve Therapeutics, Inc., Immuneering Corp, Pyxis Oncology, Inc., Elevation Oncology, Inc., Ambrx Biopharma Inc., Biomea Fusion, Inc., Rain Therapeutics Inc., Olema Pharmaceuticals, Inc., and MoonLake Immunotherapeutics.

SEC CIK

Cormorant Private Healthcare Fund III LP's CIK is 0001817320

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prometheus Biosciences, Inc.

Investor

Updated Mar 18, 2021


Form 4	20.29%	375.00K	$19.00	—	Mar 18, 2021	2.22M	Purchase	—	Mar 16
Form 3/A	—	—	—	—	Mar 18, 2021	—	—	—	—
Form 3	—	—	—	—	Mar 11, 2021	—	—	—	—

Showing 3 results

Ambrx Biopharma, Inc.

Investor

Updated Oct 25, 2023


Form 4	17.18%	750.00K	$20.00	—	Apr 01, 2021	5.11M	Purchase	—	Mar 30
Form 3	—	—	—	—	Mar 25, 2021	—	—	—	—


Form 4	—	—	—	—	Aug 04, 2021	426.39K	Options	—	Aug 02
Form 3	—	—	—	—	Jul 28, 2021	—	—	—	—


Form 4	79.59%	625.00K	$16.00	—	Oct 27, 2021	1.41M	Purchase	—	Oct 25
Form 3	—	—	—	—	Oct 20, 2021	—	—	—	—


Form 4	41.26%	312.50K	$16.00	—	Sep 21, 2021	1.07M	Purchase	—	Sep 17
Form 3	—	—	—	—	Sep 14, 2021	—	—	—	—


Form 4	—	5.80M	$19.00	—	Jun 30, 2021	3.20M	Purchase	—	Jun 28
Form 3	—	—	—	—	Jun 23, 2021	—	—	—	—


Form 4	38.77%	275.00K	$19.00	—	Jun 23, 2021	984.22K	Purchase	—	Jun 21
Form 3	—	—	—	—	Jun 16, 2021	—	—	—	—


Form 4	-12.14%	-400.00K	$2.90	-$1.16M	Apr 03, 2024	2.90M	Sale	—	Apr 01
Form 4	-21.62%	-909.09K	$3.02	-$2.75M	Mar 18, 2024	3.30M	Sale	—	Mar 14 - Mar 15
Form 3	—	—	—	—	Apr 24, 2023	4.20M	—	—	—
Form 4	32.30%	550.00K	$15.00	—	Aug 05, 2021	2.25M	Purchase	—	Aug 03
Form 3	—	—	—	—	Jul 29, 2021	—	—	—	—


Form 4	67.28%	450.00K	$16.00	—	Oct 15, 2021	1.12M	Purchase	—	Oct 13
Form 3	—	—	—	—	Oct 07, 2021	—	—	—	—


Form 4	12.61%	250.00K	$16.00	—	Jul 01, 2021	2.23M	Purchase	—	Jun 29
Form 3	—	—	—	—	Jun 24, 2021	—	—	—	—


Form 4	3.20%	2.15M	$9.12	$19.63M	Sep 19, 2023	69.47M	Purchase	—	Sep 15 - Sep 18
Form 4	8.40%	5.22M	$11.30	$58.95M	Apr 20, 2023	67.31M	Purchase	—	Apr 18 - Apr 20
Form 4	4.37%	2.60M	$9.75	$25.32M	Apr 17, 2023	62.10M	Purchase	—	Apr 13 - Apr 17
Form 4	1.90%	1.00M	$10.21	$10.21M	Mar 16, 2023	53.50M	Purchase	—	Mar 14 - Mar 16
Form 3	—	—	—	—	Mar 13, 2023	52.50M	—	—	—


Form 4	—	51.02K	—	—	Jun 13, 2024	3.63M	Grant	—	Jun 12
Form 4	—	6.99K	—	—	Jun 16, 2023	3.63M	Grant	—	Jun 14
Form 4	12.61%	400.00K	$30.00	$12.00M	Apr 03, 2023	3.62M	Purchase	—	Mar 30
Form 4	—	23.87K	—	—	Jun 24, 2022	3.22M	Grant	—	Jun 22
Form 4	—	5.44M	$17.00	—	Apr 22, 2021	3.20M	Purchase	—	Apr 20
Form 4	-50.00%	-28.91K	—	—	Apr 19, 2021	2.30M	Grant	—	Apr 15
Form 3	—	—	—	—	Apr 15, 2021	—	—	—	—


Form 4	10.51%	264.10K	$17.00	—	Apr 29, 2021	2.78M	Purchase	—	Apr 27
Form 3	—	—	—	—	Apr 22, 2021	—	—	—	—


Form 4	14.94%	425.00K	$19.00	—	Nov 23, 2020	3.27M	Purchase	—	Nov 23
Form 3	—	—	—	—	Nov 18, 2020	—	—	—	—


Form 4	0.70%	58.84K	$59.90	$3.52M	Oct 10, 2023	8.49M	Purchase	—	Oct 05
Form 4	3.60%	293.21K	$57.30	$16.80M	Oct 04, 2023	8.44M	Purchase	—	Oct 02 - Oct 04

Benzinga

Benzinga

Cormorant Private Healthcare Fund III LP's Net Worth

Who is Cormorant Private Healthcare Fund III LP

SEC CIK

Past Insider Trading and Trends

Prometheus Biosciences, Inc.

Ambrx Biopharma, Inc.

Design Therapeutics, Inc.

Icosavax, Inc.

Ventyx Biosciences, Inc.

Tyra Biosciences, Inc.

Monte Rosa Therapeutics, Inc.

Verve Therapeutics, Inc.

Immuneering Corp

Pyxis Oncology, Inc.

Elevation Oncology, Inc.

Ambrx Biopharma Inc.

Biomea Fusion, Inc.

Rain Therapeutics Inc.

Olema Pharmaceuticals, Inc.

MoonLake Immunotherapeutics

OnKure Therapeutics, Inc.